Novo Biosciences

Novo Biosciences

A pharmaceutical company that uses a zebrafish drug-screening platform to find drug candidate molecules that have the capacity to promote regeneration of tissues. Their drug candidate MSI-1436 is being developed and tested for the treatment of heart disease, Duchenne Muscular Dystrophy and diabetic nephropathy.

# Contributions
Last Contribution
14 Sep 2019 1:47 pm
10 Sep 2019 2:02 am